Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders
Heart failure, the leading cause of mortality and morbidity in the developed world, is characterized by cardiac ryanodine receptor 2 channels that are hyperphosphorylated, oxidized, and depleted of the stabilizing subunit calstabin-2. This results in a diastolic sarcoplasmic reticulum Ca<sup>2+</sup> leak that impairs cardiac contractility and triggers arrhythmias. Genetic mutations in ryanodine receptor 2 can also cause Ca<sup>2+</sup> leak, leading to arrhythmias and sudden cardiac death. Here, we solved the cryogenic electron microscopy structures of ryanodine receptor 2 variants linked either to heart failure or inherited sudden cardiac death. All are in the primed state, part way between closed and open. Binding of Rycal drugs to ryanodine receptor 2 channels reverts the primed state back towards the closed state, decreasing Ca<sup>2+</sup> leak, improving cardiac function, and preventing arrhythmias. We propose a structural-physiological mechanism whereby the ryanodine receptor 2 channel primed state underlies the arrhythmias in heart failure and arrhythmogenic disorders.
Authors
- Qi Yuan (ORCID: https://orcid.org/0000-0002-9837-8495)
- Marco Miotto (ORCID: https://orcid.org/0000-0001-8851-4863)
- Andrew R. Marks (ORCID: https://orcid.org/0000-0002-4316-5775)
- Gunnar Weninger (ORCID: https://orcid.org/0009-0009-1836-4316)
- Anetta Wronska (ORCID: https://orcid.org/0000-0003-2288-2596)
- Steve Reiken (ORCID: https://orcid.org/0000-0002-5807-3574)
- Haikel Dridi (ORCID: https://orcid.org/0000-0001-9533-7367)
- Carl Tchagou
- Liu Yang (ORCID: https://orcid.org/0000-0002-6498-4702)
Institutions
- Columbia University Irving Medical Center (US)
- Columbia University (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2024-09-15
- DOI
- https://doi.org/10.1038/s41467-024-51791-y
- Citations
- 30
- Primary Topic
- Cardiac electrophysiology and arrhythmias
- Type
- article
- Field-Weighted Citation Impact
- 12.06
Funders
- National Institutes of Health
- University of California, San Francisco
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases